Skip to content

FDA may change emergency use authorization to allow booster shots to immunocompromised people

The FDA may soon amend the emergency use authorizations for the Pfizer and Moderna vaccines to allow a Covid-19 booster shot for those with compromised immune systems.

The CDC says that 2.7% of adults in the country are immunocompromised and this includes patients with cancer, organ transplants and HIV.

The CDC vaccine advisory group is scheduled to meet Friday and discuss exactly who should receive a booster shot if approved, but cannot recommend them until the FDA is involved.

Categories: HealthNews